Farallon Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-800,000
| Closed | -$41.3M | – | 314 |
|
|
2022
Q3 | $41.3M | Buy |
+800,000
| New | +$41.3M | 0.23% | 76 |
|
|
2022
Q1 | – | Sell |
-935,463
| Closed | -$34.1M | – | 345 |
|
|
2021
Q4 | $34.1M | Buy |
935,463
+549,463
| +142% | +$20M | 0.17% | 76 |
|
|
2021
Q3 | $6.6M | Buy |
+386,000
| New | +$6.6M | 0.03% | 169 |
|
|
2020
Q1 | – | Sell |
-1,500,000
| Closed | -$59.3M | – | 118 |
|
|
2019
Q4 | $59.3M | Sell |
1,500,000
-513,396
| -25% | -$20.3M | 0.4% | 47 |
|
|
2019
Q3 | $13.7M | Buy |
2,013,396
+13,396
| +0.7% | +$90.8K | 0.1% | 79 |
|
|
2019
Q2 | $18.6M | Buy |
2,000,000
+500,000
| +33% | +$4.65M | 0.12% | 78 |
|
|
2019
Q1 | $20.8M | Buy |
1,500,000
+50,000
| +3% | +$695K | 0.16% | 69 |
|
|
2018
Q4 | $15.8M | Buy |
1,450,000
+300,000
| +26% | +$3.27M | 0.12% | 69 |
|
|
2018
Q3 | $14.5M | Hold |
1,150,000
| – | – | 0.09% | 76 |
|
|
2018
Q2 | $15.1M | Buy |
1,150,000
+200,000
| +21% | +$2.63M | 0.09% | 65 |
|
|
2018
Q1 | $12.9M | Buy |
+950,000
| New | +$12.9M | 0.09% | 68 |
|